EUVIMEDEUVIMED entdecken
Open Access

Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts

Katherine Ilia iD, Nika Shakiba iD, Trevor Bingham iD, Ross D Jones iD, Michael M Kaminski iD, Eliezer Aravera, Simone Bruno iD, Sebastian Palacios, Ron Weiss iD, James J Collins iD, Domitilla Del Vecchio iD, Thorsten M Schlaeger iD

Science Advances · 2023

DOI: 10.1126/sciadv.adg8495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Katherine Ilia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Cellular Reprogramming, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reprogramming human fibroblasts to induced pluripotent stem cells (iPSCs) is inefficient, with heterogeneity among transcription factor (TF) trajectories driving divergent cell states. Nevertheless, the impact of TF dynamics on reprogramming efficiency remains uncharted. We develop a system that accurately reports OCT4 protein levels in live cells and use it to reveal the trajectories of OCT4 in successful reprogramming. Our system comprises a synthetic genetic circuit that leverages noise to generate a wide range of OCT4 trajectories and a microRNA targeting endogenous OCT4 to set total cellular OCT4 protein levels. By fusing OCT4 to a fluorescent protein, we are able to track OCT4 trajectories with clonal resolution via live-cell imaging. We discover that a supraphysiological, stable OCT4 level is required, but not sufficient, for efficient iPSC colony formation. Our synthetic genetic circuit design and high-throughput live-imaging pipeline are generalizable for investigating TF dynamics for other cell fate programming applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular ReprogrammingInduced Pluripotent Stem CellsHumansCell DifferentiationCells, CulturedFibroblastsTranscription FactorsOctamer Transcription Factor-3

Substanzen

Transcription FactorsPOU5F1 protein, humanOctamer Transcription Factor-3

Autor:innen und Institutionen

  • Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
  • Institute for Medical Engineering and Science, MIT, Cambridge, MA 02139, USA.
  • Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • School of Biomedical Engineering, University of British Columbia, Vancouver, British Columbia V6T 1Z3 Canada.
  • Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA.
  • Harvard University, Boston, MA 02115, USA.

ORCID-Profile: Katherine Ilia, Nika Shakiba, Trevor Bingham, Ross D Jones, Michael M Kaminski, Simone Bruno, Ron Weiss, James J Collins, Domitilla Del Vecchio, Thorsten M Schlaeger

Förderung

  • NIBIB NIH HHS

Zitieren

APA

Ilia, K., Shakiba, N., Bingham, T., Jones, R. D., Kaminski, M. M., Aravera, E., Bruno, S., Palacios, S., Weiss, R., Collins, J. J., Del Vecchio, D., & Schlaeger, T. M. (2023). Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts. Science Advances. https://doi.org/10.1126/sciadv.adg8495

Vancouver

Ilia K, Shakiba N, Bingham T, Jones RD, Kaminski MM, Aravera E, et al. Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts. Science Advances. 2023. doi:10.1126/sciadv.adg8495

BibTeX
@article{Ilia2023,
  author = {Ilia, Katherine and Shakiba, Nika and Bingham, Trevor and Jones, Ross D and Kaminski, Michael M and Aravera, Eliezer and Bruno, Simone and Palacios, Sebastian and Weiss, Ron and Collins, James J and Del Vecchio, Domitilla and Schlaeger, Thorsten M},
  title = {Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.adg8495}
}
Kostenlos starten →